Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male SurvivorsElizabeth S Higgs, Dehkontee Gayedyu-Dennis, William A Fischer Ii, et al.The Lancet. Infectious Diseases|May 19, 2022
Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort studyJ Daniel Kelly, Collin Van Ryn, Moses Badio, et al.The Journal of Infectious Diseases|September 1, 2022
Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening AlgorithmsDehkontee Gayedyu-Dennis, Mosoka P Fallah, Clara Drew, et al.PLOS Global Public Health|January 27, 2026
Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in LiberiaMoses Badio, Meekie Glayweon, Collin Van Ryn, et al.The Lancet. Microbe|March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control studyMosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.The New England Journal of Medicine|March 12, 2019
A Longitudinal Study of Ebola Sequelae in Liberia, Michael C Sneller, Cavan Reilly, et al.PLOS Global Public Health|June 20, 2023
Challenges of conducting an international observational study to assess immunogenicity of multiple COVID-19 vaccinesRatna Sardana, Placide Mbala Kingebeni, Wiwit Agung Snc, et al.The Lancet. Global Health|June 22, 2023
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort studyMosoka P Fallah, Cavan Reilly, Collin Van Ryn, et al.Plos One|November 14, 2024
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.Plos One|September 15, 2022
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd, et al.Pageof 1